← all works
Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.
Machine scores (provisional)
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Opus teacher head0.026
GPT teacher head0.378
- Teacher spread
- 0.352 · how far apart the two teachers sit on this one work
- Validation status
score_only:v0-immature-baseline· verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- Nature reviews. Cancer
- Topic
- Protease and Inhibitor Mechanisms
- Field
- Biochemistry, Genetics and Molecular Biology
- Canadian institutions
- University of British Columbia
- Funders
- National Cancer InstituteNovartis Institutes for BioMedical ResearchCanadian Breast Cancer Research AllianceBreast Cancer Alliance
- Keywords
- Matrix metalloproteinaseMatrix metalloproteinase inhibitorDrugDrug developmentCancer researchPharmacologyExtracellular matrixClinical trialCarcinogenesisCancerMedicineBioinformaticsComputational biologyBiologyCell biologyInternal medicine
- Has abstract in OpenAlex
- no